Vir Biotechnology, Inc. VIR Business Segments — Contract manufacturing
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Vir Biotechnology, Inc. in its filing.
Tagged under the XBRL concept vir:ResearchAndDevelopmentContractManufacturing.
The official record: Vir Biotechnology, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Vir Biotechnology, Inc.'s business segments — contract manufacturing.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Vir Biotechnology, Inc.'s business segments — contract manufacturing?
- Vir Biotechnology, Inc. (VIR) reported business segments — contract manufacturing of $36.01M in Q1 2026.
- How has Vir Biotechnology, Inc.'s business segments — contract manufacturing changed year-over-year?
- Vir Biotechnology, Inc.'s business segments — contract manufacturing increased by 285.7% year-over-year, from $9.34M to $36.01M.
- What is the long-term trend for Vir Biotechnology, Inc.'s business segments — contract manufacturing?
- Over 3 years (2022 to 2025), Vir Biotechnology, Inc.'s business segments — contract manufacturing has grown at a -0.2% compound annual growth rate (CAGR), from $47.96M to $47.62M.
- What does business segments — contract manufacturing mean?
- Refers to the expenses incurred by the segment for outsourcing the production of clinical or commercial drug supplies to third-party manufacturers. Monitoring this cost helps assess the company's reliance on external manufacturing partners and the scalability of its production processes.